Pharmacy workers embark on a multiday strike; Fathers are taking paid family leave to bond with their newborns; the FDA is set to evaluate a pioneering gene therapy for sickle cell disease (SCD).
US Pharmacy Staff Stage Nationwide Walkout
Pharmacy staff in the United States are taking a stand against what they perceive as unsafe working conditions, according to CNBC. Organizing under the banner "Pharmageddon," employees from Walgreens, CVS, and Rite Aid, among others, are engaging in a nationwide walkout this week to protest understaffing, inadequate compensation, and excessive work demands, which have been exacerbated by COVID-19 pandemic. The walkout follows separate incidents of pharmacy staff protests in Walgreens and CVS locations earlier this year and signals a push for unionization and improved patient awareness regarding their working conditions.
Dads Embrace Paid Family Leave to Bond With Newborns
A significant cultural shift is taking place in the United States, as more fathers are opting to take paid family leave to bond with their newborns and support their partners during the early stages of parenthood, according to Kaiser Health News. The total number of men taking paid leave increased by 19% in California’s fiscal year ending in June 2023, a change that can be attributed to evolving attitudes among a new generation of fathers and increased employer support for male parental leave, further reinforced during the COVID-19 pandemic. Although the positive effects of this shift on mothers' health have been documented, the effects on children are still under examination.
FDA to Review CRISPR-Based Gene Therapy for Sickle Cell Disease
A groundbreaking gene therapy that leverages CRISPR gene editing technology is being reviewed by the FDA as a potential treatment for sickle cell disease (SCD), a hereditary blood disorder primarily affecting Black individuals in the United States, according to The Associated Press. This gene therapy, exagamglogene autotemcel, is a 1-time treatment that aims to address the genetic root of the disease. Current treatments for SCD involve medications and blood transfusions, with the only permanent solution being a bone marrow transplant, which comes with various challenges, including finding a well-matched donor.
Atypical Marker Expression in T-Cell Acute Lymphoblastic Leukemia/Lymphoma
May 15th 2024Two unique case reports highlight the diagnostic challenges and critical importance of comprehensive immunophenotyping in cases of T-cell acute lymphoblastic leukemia/lymphoma that present without typical immaturity markers but with rare γδ T-cell receptor expression.
Read More
Panel Addresses Minority Physician Shortage, Maternal Health, at Senate Committee Hearing
May 15th 2024The senate hearing held by the US Senate Committee on Health, Education, Labor, and Pensions, led by Sen. Bernie Sanders (I, Vermont), chairman of the committee, and ranking member Sen. Bill Cassidy, MD, (R, Louisiana), addressed the critical issue of physician and health care worker shortages, as well as the maternal health crisis, in the US.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Patients With MG Report Higher Azathioprine Discontinuation vs Other Immunosuppressants
May 15th 2024Survey data from over 200 patients showed that treatment discontinuation was lower for those taking mycophenolate or methotrexate than for those taking azathioprine for their myasthenia gravis (MG).
Read More
Bleeds and Resource Use in Hemophilia B: Retrospective Observational Study
May 15th 2024This real-world US study describes individuals with hemophilia B who experience bleeds despite factor replacement therapy and quantifies the associated comorbidity and health care resource utilization burden.
Read More